4//SEC Filing
FONTEYNE PAUL R. 4
Accession 0000899243-22-001527
CIK 0001658551other
Filed
Jan 9, 7:00 PM ET
Accepted
Jan 10, 8:37 PM ET
Size
6.9 KB
Accession
0000899243-22-001527
Insider Transaction Report
Form 4
FONTEYNE PAUL R.
Director
Transactions
- Purchase
Common Stock
2022-01-06$19.00/sh+3,947$74,993→ 3,947 total - Award
Stock Option (Right to Buy)
2022-01-06+8,400→ 8,400 totalExercise: $19.00Exp: 2032-01-06→ Common Stock (8,400 underlying)
Footnotes (1)
- [F1]This option shall vest in full on the date of the Corporation's 2022 Annual Stockholders Meeting, subject to the Reporting Person's continuous service to the Issuer through such vesting date.
Documents
Issuer
Amylyx Pharmaceuticals, Inc.
CIK 0001658551
Entity typeother
Related Parties
1- filerCIK 0001727550
Filing Metadata
- Form type
- 4
- Filed
- Jan 9, 7:00 PM ET
- Accepted
- Jan 10, 8:37 PM ET
- Size
- 6.9 KB